Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma

E-ISSN： 1365-2559|66|5|706-714

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.5, 2015-04, pp. : 706-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BARX2 in hepatocellular carcinoma

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 228-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of p27^KIP1 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Oncology, Vol. 58, Iss. 2, 2000-02 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 6, 2015-11 ,pp. : 585-591

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma

HISTOPATHOLOGY, Vol. 66, Iss. 4, 2015-03 ,pp. : 508-516

John Wiley & Sons Inc

Access to resources Recommend Favorite

RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1480-1496

John Wiley & Sons Inc

Access to resources Recommend Favorite